首页> 外文会议>Proceedings of the Fourth China-Jpan international congress of mycology >Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma
【24h】

Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma

机译:伊曲康唑治疗肺曲霉病的多中心临床试验

获取原文
获取原文并翻译 | 示例

摘要

Itraconazole 100-200mg was orally administered to 49 patients with pulmonary aspergilloma once a day in principle immediately after breakfast. drug concentrations in fungus balls and in aspergilloma cavities were determined in each measurable case and the data were evaluated in terms of efficacy and afety.
机译:原则上每天早餐后立即每天一次对49例肺曲霉菌瘤患者口服100-200mg伊曲康唑。在每个可测量的病例中确定真菌球和曲霉菌腔中的药物浓度,并根据功效和安全性评估数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号